In conclusion, NAC treatment attenuates the development of hypertension in young SHR, which is correlated with a reduction in plasma ADMA levels, a decrease in superoxide production, and an increase in DDAH activity and GSH/GSSG ratio in the SHR kidney. This evidence concerns the gene DDAH2 and hypertensive disorder.